BIOTEX SCHEDULE 13G

Company

SOLIGENIX, INC.

Filed

July 2, 2009

Accession Number

0001009448-09-000052

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →